Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) comprises a spectrum of liver diseases, ranging from liver steatosis to metabolic dysfunction-associated steatohepatitis (MASH), increasing the risk of developing cirrhosis and hepatocellular carcinoma (HCC). Fibrosis within MASLD is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Schilcher, Katharina, Dayoub, Rania, Kubitza, Marion, Riepl, Jakob, Klein, Kathrin, Buechler, Christa, Melter, Michael, Weiss, Thomas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487578/
https://www.ncbi.nlm.nih.gov/pubmed/37686029
http://dx.doi.org/10.3390/ijms241713222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487578/
https://www.ncbi.nlm.nih.gov/pubmed/37686029
http://dx.doi.org/10.3390/ijms241713222

Ejemplares similares